The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma

Multiple myeloma (MM) is typically featured by the increased levels of inflammatory cytokines in the neoplastic plasma cells (PCs) producing monoclonal immunoglobulin. PCs proliferate in the bone marrow, which will lead to extensive skeletal destruction with osteolytic lesions, osteopenia, or pathol...

Full description

Bibliographic Details
Main Authors: Cheng-Der Liu, Chun-Chun Chang, Wei-Han Huang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Tzu-Chi Medical Journal
Subjects:
Online Access:http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2021;volume=33;issue=3;spage=257;epage=262;aulast=Liu
id doaj-579195713f4d482b906d9e60d37a917b
record_format Article
spelling doaj-579195713f4d482b906d9e60d37a917b2021-07-07T14:42:04ZengWolters Kluwer Medknow PublicationsTzu-Chi Medical Journal1016-31902223-89562021-01-0133325726210.4103/tcmj.tcmj_141_20The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myelomaCheng-Der LiuChun-Chun ChangWei-Han HuangMultiple myeloma (MM) is typically featured by the increased levels of inflammatory cytokines in the neoplastic plasma cells (PCs) producing monoclonal immunoglobulin. PCs proliferate in the bone marrow, which will lead to extensive skeletal destruction with osteolytic lesions, osteopenia, or pathologic fractures. The diagnostic biology of MM has progressed from morphology and low-sensitivity protein analysis into multiomics-based high-throughput readout, whereas therapeutics has evolved from single active agent to potential active drug combinations underlying precision medicine. Many studies have focused on the cytokine networks that control growth, progression, and dissemination of the disease. The complexity of cytokines in MM development remains to be elucidated comprehensively. Apart from knowing that interleukin (IL)-6 is important in the pathogenesis of MM, it has been shown that IL-6 is a paracrine factor supplied by the microenvironment comprising of those cells from the myeloid compartment. Due to IL-10 was considered an immunosuppressive cytokine to promote cancer escape from immune surveillance, the role of IL-10 in this regard has been underestimated although recent advances have reported that IL-10 induces both PC proliferation and angiogenesis in MM. In addition, cumulative studies have suggested that IL-10 plays an important role in the induction of chemoresistance in many cancers; a virtual requirement of autocrine IL-10 for MM cells to escape from an IL-6-dependent proliferation loop was implicated. In this review, we summarize the available information to elucidate a new understanding of the molecular and functional roles of IL-10 in MM.http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2021;volume=33;issue=3;spage=257;epage=262;aulast=Liuinterleukin-10interleukin-10 targetingmultiple myelomaproliferationtumorigenesis
collection DOAJ
language English
format Article
sources DOAJ
author Cheng-Der Liu
Chun-Chun Chang
Wei-Han Huang
spellingShingle Cheng-Der Liu
Chun-Chun Chang
Wei-Han Huang
The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
Tzu-Chi Medical Journal
interleukin-10
interleukin-10 targeting
multiple myeloma
proliferation
tumorigenesis
author_facet Cheng-Der Liu
Chun-Chun Chang
Wei-Han Huang
author_sort Cheng-Der Liu
title The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
title_short The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
title_full The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
title_fullStr The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
title_full_unstemmed The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
title_sort perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
publisher Wolters Kluwer Medknow Publications
series Tzu-Chi Medical Journal
issn 1016-3190
2223-8956
publishDate 2021-01-01
description Multiple myeloma (MM) is typically featured by the increased levels of inflammatory cytokines in the neoplastic plasma cells (PCs) producing monoclonal immunoglobulin. PCs proliferate in the bone marrow, which will lead to extensive skeletal destruction with osteolytic lesions, osteopenia, or pathologic fractures. The diagnostic biology of MM has progressed from morphology and low-sensitivity protein analysis into multiomics-based high-throughput readout, whereas therapeutics has evolved from single active agent to potential active drug combinations underlying precision medicine. Many studies have focused on the cytokine networks that control growth, progression, and dissemination of the disease. The complexity of cytokines in MM development remains to be elucidated comprehensively. Apart from knowing that interleukin (IL)-6 is important in the pathogenesis of MM, it has been shown that IL-6 is a paracrine factor supplied by the microenvironment comprising of those cells from the myeloid compartment. Due to IL-10 was considered an immunosuppressive cytokine to promote cancer escape from immune surveillance, the role of IL-10 in this regard has been underestimated although recent advances have reported that IL-10 induces both PC proliferation and angiogenesis in MM. In addition, cumulative studies have suggested that IL-10 plays an important role in the induction of chemoresistance in many cancers; a virtual requirement of autocrine IL-10 for MM cells to escape from an IL-6-dependent proliferation loop was implicated. In this review, we summarize the available information to elucidate a new understanding of the molecular and functional roles of IL-10 in MM.
topic interleukin-10
interleukin-10 targeting
multiple myeloma
proliferation
tumorigenesis
url http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2021;volume=33;issue=3;spage=257;epage=262;aulast=Liu
work_keys_str_mv AT chengderliu theperspectivesofinterleukin10inthepathogenesisandtherapeuticsofmultiplemyeloma
AT chunchunchang theperspectivesofinterleukin10inthepathogenesisandtherapeuticsofmultiplemyeloma
AT weihanhuang theperspectivesofinterleukin10inthepathogenesisandtherapeuticsofmultiplemyeloma
AT chengderliu perspectivesofinterleukin10inthepathogenesisandtherapeuticsofmultiplemyeloma
AT chunchunchang perspectivesofinterleukin10inthepathogenesisandtherapeuticsofmultiplemyeloma
AT weihanhuang perspectivesofinterleukin10inthepathogenesisandtherapeuticsofmultiplemyeloma
_version_ 1721315125505294336